Ionis Pharmaceuticals Inc (IONS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.84B
Last updated: Nov 17, 2026 at 4:38 PM ET
Ionis Pharmaceuticals Inc (IONS) Stock Chart
Ionis Pharmaceuticals (IONS) has a latest price of $26.96 on Nov 17, 2026. Its price fell 62.3% over the past 12 months. The month-end price rose 67.5% over the 10 years through Oct 2026, a compound annual rate of 5.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $82.73 in Nov 2025 and its lowest $25.98 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IONS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IONS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 55.7%, and over 6 months it fell 63.5%. The month-end price fell 1.7% over the 3 years through Oct 2026, a compound annual decline of 0.6%.
| Period | Change |
|---|---|
| 1 month | -39.3% |
| 3 months | -55.7% |
| 6 months | -63.5% |
| 12 months | -62.3% |
| 12 months, with dividends | -62.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -1.7% | -0.6% |
| 5 years | +36.6% | +6.4% |
| 10 years | +67.5% | +5.3% |
Price by Year
Its best calendar year was 2025, when the price rose 126.3%, and its weakest was 2021, when it fell 46.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $43.52 | -45.0% |
| 2025 | $79.11 | +126.3% |
| 2024 | $34.96 | -30.9% |
| 2023 | $50.59 | +33.9% |
| 2022 | $37.77 | +24.1% |
| 2021 | $30.43 | -46.2% |
| 2020 | $56.54 | -6.4% |
| 2019 | $60.41 | +11.7% |
| 2018 | $54.06 | +7.5% |
| 2017 | $50.30 | +5.2% |
Trading Range
The price is 36.5% below its 50-day average of $42.46 and 57.8% below its 200-day average of $63.94.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $26.96 | |
| 50-day average | $42.46 | -36.5% |
| 200-day average | $63.94 | -57.8% |
Price Risk
Over 3 years, its largest fall from a peak was 68.8%.
| Measure | Value |
|---|---|
| 1-year beta | 0.34 |
| Largest fall, 1 year | -68.8% |
| Largest fall, 3 years | -68.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IONS
What is IONS's 1-year price change?
Ionis Pharmaceuticals's price fell 62.3% over the past 12 months. With dividends included, the 12-month total return was -62.3%.
What is IONS's 5-year price change?
Ionis Pharmaceuticals's month-end price rose 36.6% over the 5 years through Oct 2026, a compound annual rate of 6.4%. These figures leave out dividends.
What is IONS's beta?
Ionis Pharmaceuticals's 1-year beta against the S&P 500 is 0.34, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 68.8%.
Is the IONS chart free?
Yes. Advanced Charting for IONS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IONS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors